At a glance
(thousands of €, if not stated otherwise) |
Second quarter of 2021 |
Second quarter of 2020 |
Six months ended 30 June 2021 |
Six months ended 30 June 2020 |
Year ended 31 December 2020 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Income statement(*) |
|
|
|
|
|
||||||
Revenues |
139,772 |
99,587 |
253,664 |
194,404 |
478,053 |
||||||
Other income |
13,298 |
14,059 |
23,564 |
22,802 |
52,207 |
||||||
R&D expenditure |
(138,866) |
(147,448) |
(268,826) |
(262,901) |
(523,667) |
||||||
S, G&A expenses |
(60,954) |
(54,371) |
(105,950) |
(88,696) |
(185,225) |
||||||
Operating expenses |
(199,820) |
(201,819) |
(374,776) |
(351,597) |
(708,892) |
||||||
Operating loss |
(46,750) |
(88,173) |
(97,548) |
(134,391) |
(178,632) |
||||||
Net financial results |
(18,209) |
(28,439) |
19,916 |
(34,144) |
(131,143) |
||||||
Taxes |
630 |
(373) |
473 |
(709) |
(1,226) |
||||||
Net loss from continuing operations |
(64,329) |
(116,986) |
(77,159) |
(169,244) |
(311,001) |
||||||
Net profit from discontinued operations, net of tax |
- |
1,944 |
22,191 |
3,601 |
5,565 |
||||||
Net loss |
(64,329) |
(115,042) |
(54,968) |
(165,643) |
(305,436) |
||||||
Balance sheet |
|
|
|
|
|
||||||
Cash and cash equivalents |
2,642,639 |
2,384,220 |
2,642,639 |
2,384,220 |
2,135,187 |
||||||
Current financial investments |
2,363,969 |
3,182,276 |
2,363,969 |
3,182,276 |
3,026,278 |
||||||
R&D incentives receivables |
142,745 |
116,629 |
142,745 |
116,629 |
135,728 |
||||||
Assets |
5,430,617 |
5,851,564 |
5,430,617 |
5,851,564 |
5,717,731 |
||||||
Shareholders' equity |
2,663,473 |
2,773,263 |
2,663,473 |
2,773,263 |
2,670,355 |
||||||
Deferred income |
2,565,292 |
2,823,833 |
2,565,292 |
2,823,833 |
2,809,133 |
||||||
Other liabilities |
201,852 |
254,468 |
201,852 |
254,468 |
238,242 |
||||||
Cash flow |
|
|
|
|
|
||||||
Operational cash burn(**) |
(95,527) |
(147,088) |
(223,196) |
(230,486) |
(517,404) |
||||||
Cash flow used in operating activities |
(81,922) |
(140,955) |
(203,131) |
(209,829) |
(427,336) |
||||||
Cash flow generated from/used in (-) investing activities |
182,194 |
(216,836) |
682,053 |
712,804 |
757,288 |
||||||
Cash flow generated from/used in (-) financing activities |
(1,952) |
16,316 |
(1,474) |
20,246 |
22,040 |
||||||
Increase/decrease (-) in cash and cash equivalents |
98,319 |
(341,474) |
477,448 |
523,222 |
351,994 |
||||||
Effect of currency exchange rate fluctuation on cash and cash equivalents |
(9,629) |
(17,878) |
22,121 |
(617) |
(70,539) |
||||||
Cash and cash equivalents at end of the period |
2,642,639 |
2,384,220 |
2,642,639 |
2,384,220 |
2,143,071 |
||||||
|
|
|
|
|
|
||||||
Cash and cash equivalents from continuing operations |
2,642,639 |
2,384,220 |
2,642,639 |
2,384,220 |
2,135,187 |
||||||
Cash and cash equivalents classified as assets held for sale |
- |
- |
- |
- |
7,884 |
||||||
Current financial investments at the end of the period |
2,363,969 |
3,182,276 |
2,363,969 |
3,182,276 |
3,026,278 |
||||||
Total current financial investments and cash and cash equivalents at the end of the period |
5,006,608 |
5,566,496 |
5,006,608 |
5,566,496 |
5,169,349 |
||||||
Financial ratios |
|
|
|
|
|
||||||
Number of shares issued at the end of the period |
65,522,521 |
65,254,562 |
65,522,521 |
65,254,562 |
65,411,767 |
||||||
Basic and diluted loss per share (in €) |
(0.98) |
(1.77) |
(0.84) |
(2.55) |
(4.69) |
||||||
Share price at the end of the period (in €) |
58.48 |
175.05 |
58.48 |
175.05 |
80.48 |
||||||
Total group employees at the end of the period (number)(***) |
1,397 |
1,280 |
1,397 |
1,280 |
1,489 |
||||||
|
|||||||||||
Employees per site as of 30 June 2021
(total: 1,397 employees)
